Stay updated on RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial page.

Latest updates to the RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedA new revision tag v3.6.5 is added to the record history and the previous tag v3.6.4 is removed, reflecting an updated build of the page history.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe history now includes a new revision entry: Revision: v3.6.4, replacing the previous Revision: v3.6.3, indicating a platform update reflected in the page's version history.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedA new revision entry 'Revision: v3.6.3' was added to the record history, replacing the previous 'Revision: v3.6.2'. This reflects an update to the page's revision notes.SummaryDifference0.1%

- Check49 days agoChange DetectedThe history shows a new page revision entry (v3.6.2) added, replacing the previous v3.6.0, indicating an updated site version for the record history. This is a metadata change that updates the revision label rather than altering trial data.SummaryDifference0.1%

- Check63 days agoChange DetectedThe history now includes a new addition stating 'No longer looking for participants,' signaling that recruitment for the study has ended. A new revision tag 'Revision: v3.6.0' was added, while the previous revision 'Revision: v3.5.5' was removed from the history.SummaryDifference0.3%

- Check70 days agoChange DetectedA new Revision: v3.5.5 appears in the history, replacing the previous Revision: v3.5.4. This update reflects a software release version change for the page rather than any changes to study data or user-facing content.SummaryDifference0.1%

Stay in the know with updates to RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial page.